Therapeutic Asset Ratings
705 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
N-Acetyl-L-Cysteine
Alpha-methylacyl-CoA Racmase Deficiency
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
N-Acetyl-L-Cysteine
Aspartylglucosaminuria
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
N-Acetyl-L-Cysteine
D-Bifunctional Enzyme Deficiency
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
N-Acetyl-L-Cysteine
Fucosidosis
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
N-Acetyl-L-Cysteine
Globoid Cell Leukodystrophy
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
N-Acetyl-L-Cysteine
Glycoprotein Metabolic Disorders
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
N-Acetyl-L-Cysteine
Hereditary Leukoencephalopathy With Axonal Spheroids (HDLS; CSF1R Mutation)
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
N-Acetyl-L-Cysteine
Hunter Syndrome
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
N-Acetyl-L-Cysteine
Hurler Syndrome
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
N-Acetyl-L-Cysteine
Infantile Refsum Disease
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
N-Acetyl-L-Cysteine
Inherited Metabolic Disorders
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
N-Acetyl-L-Cysteine
Maroteaux Lamy Syndrome
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
N-Acetyl-L-Cysteine
Metachromatic Leukodystrophy
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
N-Acetyl-L-Cysteine
Mitochondrial Neurogastrointestingal Encephalopathy
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
N-Acetyl-L-Cysteine
Mucopolysaccharidosis Disorders
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
N-Acetyl-L-Cysteine
Multifunctional Enzyme Deficiency
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
N-Acetyl-L-Cysteine
Neonatal Adrenoleukodystrophy
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
N-Acetyl-L-Cysteine
Niemann-Pick B
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
N-Acetyl-L-Cysteine
Niemann-Pick C Subtype 2
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
N-Acetyl-L-Cysteine
Peroxisomal Disorders
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
N-Acetyl-L-Cysteine
Recessive Leukodystrophies
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
N-Acetyl-L-Cysteine
Severe Osteopetrosis
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
N-Acetyl-L-Cysteine
Sly Syndrome
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
N-Acetyl-L-Cysteine
Sphingolipidoses
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
N-Acetyl-L-Cysteine
Sphingomyelin Deficiency
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Showing 476 to 500 of 705 assets
Previous
Page 20 of 29
Next